Diabetes-related foot ulcers are often associated with numbness in the feet. According to patients, the fact that these ulcers can also cause severe and unpredictable pain does not receive sufficient attention within the healthcare system, according to a doctoral thesis from the University of Gothenburg.

3 Nov 2026

Private equity hospice buyouts drive up Medicare spending

A study of for-profit hospices acquired by private equity firms found that Medicare spending rose by 5.9 percent per hospice stay after acquisition, compared with similar for-profit hospices that weren't acquired.

3 Nov 2026

AI-powered heart MRI measurements better predict patients' survival

Artificial intelligence (AI) measurements of heart function from MRI scans are more strongly linked to how long patients live after their scan than measurements made by clinicians, suggesting that AI could provide a useful first-line approach to measuring heart function.

2 Nov 2026

Global pediatric stroke burden remains high despite declining mortality

Pediatric stroke has been less recognized than adult stroke, and its risk factors, epidemiology and outcomes remain insufficiently understood.

2 Nov 2026

Wearable devices and AI provide early warning signs of hypertensive crises

Using artificial intelligence (AI) to analyze patterns in measures from a portable cuff-based blood pressure monitor and health data from a wrist-worn device may help identify when adults with stage 2 high blood pressure (blood pressure ≥140/90 mm Hg) are at increased risk of a dangerously high blood pressure episode (>180/120 mm Hg with acute end-organ damage), known as a hypertensive crisis, up to three days before it occurs, according to new, independent, preliminary research to be presented at the American Heart Association's Scientific Sessions 2026.

2 Nov 2026

Long-term study supports cardiovascular safety of contemporary hormone replacement therapy

Contemporary hormone replacement therapy (HRT) was not associated with an increased risk for heart attack, stroke, blood clots or death among women ages 45 to 59, according to a large, long-term study of over 52,000 women in Israel.

2 Nov 2026

New study links cannabis use to increased cardiovascular risk

Cannabis use, including marijuana, appears to be linked with increased cardiovascular risk, especially for stroke, making it an important consideration for heart disease and stroke prevention and counseling, according to independent, new preliminary research to be presented at the American Heart Association's Scientific Sessions 2026.

2 Nov 2026

Extreme heat spikes hospital intensive care cardiac arrest admissions

As daily temperatures climbed above 90 degrees Fahrenheit (F) across the U.S., so did the rate of out-of-hospital (OHCA) cardiac arrest admissions to hospitals intensive care units (ICUs); however, the heat didn't appear to impact the overall outcomes of people admitted for cardiac arrest during heat waves compared to other times, according to new, independent, preliminary research to be presented at the American Heart Association's Resuscitation Science Symposium 2026.

2 Nov 2026

New study evaluates quantum machine learning for lung cancer prediction

Developing reliable machine learning models for healthcare can be challenging when only small datasets are available. This challenge motivates research into whether quantum computing approaches can learn useful patterns from limited symptom and risk-factor data.

2 Nov 2026

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Dr. Laura Ajram leads the British Neuroscience Association, focusing on enhancing neuroscience research through strategic partnerships and patient engagement.

2 Nov 2026

Australian Health Data Evidence Network formed to standardize real world medical records

Australia is missing an opportunity in how to improve data-driven healthcare.

2 Nov 2026

$4 million NIH grant advances AI-guided heart failure treatment

A $4 million grant from the National Institutes of Health is helping faculty researchers in the University of Virginia School of Engineering and Applied Science develop an artificial intelligence tool to personalize treatments for people with heart failure.

30 Oct 2026

Nanoscale particle shows potential as customizable delivery vehicle for personalized cancer vaccines

A nanoscale particle with a unique structure, developed at MIT, holds potential as a customizable delivery vehicle for personalized cancer vaccines.

30 Oct 2026

New FAIR Health platform maps chronic disease prevalence across the United States

Today, FAIR Health launches FAIR Health Atlas, a free epidemiological reporting platform incorporating data on the commercially insured population.

30 Oct 2026

Mount Sinai ranks third globally among the world's smartest hospitals

The Mount Sinai Hospital has been ranked No. 3 in the world on Newsweek's "World's Best Smart Hospitals" list, rising two places from No. 5 last year and maintaining its No. 1 ranking in New York State for the second consecutive year. Mount Sinai Morningside and Mount Sinai West ranked No. 7 in New York State on the same list.

30 Oct 2026

FDA approves ILUMYA for adults with active psoriatic arthritis

Sun Pharmaceutical Industries Limited announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ILUMYA® (tildrakizumab-asmn) for the treatment of adults with active psoriatic arthritis (PsA).

30 Oct 2026

Physiological signals help AI predict post-concussion headaches and fatigue

Some people who suffer a concussion struggle with headaches and fatigue afterwards. Headaches and fatigue follow a consistent pattern that could potentially be used to warn the patient a full day before the symptoms set in.

30 Oct 2026

Hospital patients treated by female physicians have better outcomes

Patients cared for by female physicians in hospital were less likely to die or be readmitted compared with those treated by male physicians, according to a new ICES study, led by a University of Toronto researcher.

30 Oct 2026

Insilico Medicine leader shares AI-driven drug discovery insights in Shanghai and Dubai

Dr. Jue Wang, Head of Global Business Development at Insilico Medicine, has been invited to attend the China Healthcare Summit in Shanghai. On the afternoon of November 3 at 16:45, she will deliver a keynote speech in the panel titled: "THE COMMODITIZATION TRAP: WHO WINS WHEN EVERYONE HAS THE SAME AI?"

30 Oct 2026

Mayo Clinic enters new medical era with precure research

Mayo Clinic researchers are uncovering the earliest shifts in disease biology - long before symptoms appear - revealing how disease takes root and opening new possibilities to identify, predict and potentially prevent disease before symptoms develop.

30 Oct 2026